124 related articles for article (PubMed ID: 23939154)
21. S-100A1 is a reliable marker in distinguishing nephrogenic adenoma from prostatic adenocarcinoma.
Cossu-Rocca P; Contini M; Brunelli M; Festa A; Pili F; Gobbo S; Eccher A; Mura A; Massarelli G; Martignoni G
Am J Surg Pathol; 2009 Jul; 33(7):1031-6. PubMed ID: 19384190
[TBL] [Abstract][Full Text] [Related]
22. Nephrogenic adenomas in pediatric patients: a morphologic and immunohistochemical study of 21 cases.
Kao CS; Kum JB; Fan R; Grignon DJ; Eble JN; Idrees MT
Pediatr Dev Pathol; 2013; 16(2):80-5. PubMed ID: 23597251
[TBL] [Abstract][Full Text] [Related]
23. Histology and immunohistochemistry of clear cell adenocarcinoma of the urethra: histogenesis and diagnostic problems.
Alexiev BA; Tavora F
Virchows Arch; 2013 Feb; 462(2):193-201. PubMed ID: 23307189
[TBL] [Abstract][Full Text] [Related]
24. Expression of PAX8 in nephrogenic adenoma and clear cell adenocarcinoma of the lower urinary tract: evidence of related histogenesis?
Tong GX; Weeden EM; Hamele-Bena D; Huan Y; Unger P; Memeo L; O'Toole K
Am J Surg Pathol; 2008 Sep; 32(9):1380-7. PubMed ID: 18670350
[TBL] [Abstract][Full Text] [Related]
25. SATB2 as a Marker of the Proximal Nephron: Expression in Nephrogenic Adenoma and Correlation With Other Renal Tubular Markers.
Ortiz-Rey JA; Álvarez-Sarria M; Conde-Ferreirós M; Morellón-Baquera R; Bellas-Pereira A; Baltazar ST; García-Acuña S; San-Miguel Fraile P; Suárez-Peñaranda JM; Fernández-Baltar C; Vieytes-Molares M; Domínguez-Arístegui P; Gómez-de María C; Fachal-Bermúdez C; González-Carreró J
Appl Immunohistochem Mol Morphol; 2023 Mar; 31(3):145-153. PubMed ID: 36744623
[TBL] [Abstract][Full Text] [Related]
26. [Detection of AMACR (P504S), P63 and 34betaE12 cocktail in the early diagnosis of prostate cancer].
Yu T; Zhu SX; Zheng S; Chen SP
Zhonghua Nan Ke Xue; 2007 Mar; 13(3):222-5. PubMed ID: 17393784
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical antibody cocktail staining (p63/HMWCK/AMACR) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarcinomas of the prostate.
Herawi M; Epstein JI
Am J Surg Pathol; 2007 Jun; 31(6):889-94. PubMed ID: 17527076
[TBL] [Abstract][Full Text] [Related]
28. [Value of new prostate cancer markers: alpha methylacyl CoA racemase (P504S) and p63].
Molinié V; Hervé JM; Lugagne PM; Yonneau L; Ellard S; Lebret T; Botto H
Prog Urol; 2005 Sep; 15(4):611-5. PubMed ID: 16459672
[TBL] [Abstract][Full Text] [Related]
29. Best practice in diagnostic immunohistochemistry: prostate carcinoma and its mimics in needle core biopsies.
Paner GP; Luthringer DJ; Amin MB
Arch Pathol Lab Med; 2008 Sep; 132(9):1388-96. PubMed ID: 18788849
[TBL] [Abstract][Full Text] [Related]
30. Nephrogenic adenoma of the urinary tract: clinical, histological, and immunohistochemical characteristics.
López JI; Schiavo-Lena M; Corominas-Cishek A; Yagüe A; Bauleth K; Guarch R; Hes O; Tardanico R
Virchows Arch; 2013 Dec; 463(6):819-25. PubMed ID: 24142157
[TBL] [Abstract][Full Text] [Related]
31. Cystic Renal Oncocytoma and Tubulocystic Renal Cell Carcinoma: Morphologic and Immunohistochemical Comparative Study.
Skenderi F; Ulamec M; Vranic S; Bilalovic N; Peckova K; Rotterova P; Kokoskova B; Trpkov K; Vesela P; Hora M; Kalusova K; Sperga M; Perez Montiel D; Alvarado Cabrero I; Bulimbasic S; Branzovsky J; Michal M; Hes O
Appl Immunohistochem Mol Morphol; 2016 Feb; 24(2):112-9. PubMed ID: 26180933
[TBL] [Abstract][Full Text] [Related]
32. Metanephric adenoma and solid variant of papillary renal cell carcinoma: common and distinctive features.
Mantoan Padilha M; Billis A; Allende D; Zhou M; Magi-Galluzzi C
Histopathology; 2013 May; 62(6):941-53. PubMed ID: 23551615
[TBL] [Abstract][Full Text] [Related]
33. Can We Identify Nephrogenic Adenoma in Urine Cytology Specimens? A Study Evaluating Previously Described Cytomorphologic Features in Correlation With PAX8 Immunohistochemical Staining Results.
McCroskey Z; Pambuccian SE; Wojcik EM; Barkan GA
Am J Clin Pathol; 2016 Mar; 145(3):373-8. PubMed ID: 27124920
[TBL] [Abstract][Full Text] [Related]
34. [New markers in prostate biopsies].
Molinié V; Baumert H
Actas Urol Esp; 2007 Oct; 31(9):1009-24. PubMed ID: 18257370
[TBL] [Abstract][Full Text] [Related]
35. The diagnostic use of ERG in resolving an "atypical glands suspicious for cancer" diagnosis in prostate biopsies beyond that provided by basal cell and α-methylacyl-CoA-racemase markers.
Shah RB; Tadros Y; Brummell B; Zhou M
Hum Pathol; 2013 May; 44(5):786-94. PubMed ID: 23158212
[TBL] [Abstract][Full Text] [Related]
36. Vasitis nodosa and related lesions: a modern immunohistochemical staining profile with special emphasis on novel diagnostic dilemmas.
Kezlarian BE; Cheng L; Gupta NS; Williamson SR
Hum Pathol; 2018 Mar; 73():164-170. PubMed ID: 29241741
[TBL] [Abstract][Full Text] [Related]
37. [Clinicopathological features and differential diagnosis of metanephric adenoma: a report of sixteen cases].
Xi CG; Fan Y; Yang XY; Liu LB; Wang JH; Hu S; Li YY; He Q
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 48(1):598-602. PubMed ID: 27538135
[TBL] [Abstract][Full Text] [Related]
38. Utility of a triple antibody cocktail intraurothelial neoplasm-3 (IUN-3-CK20/CD44s/p53) and α-methylacyl-CoA racemase (AMACR) in the distinction of urothelial carcinoma in situ (CIS) and reactive urothelial atypia.
Aron M; Luthringer DJ; McKenney JK; Hansel DE; Westfall DE; Parakh R; Mohanty SK; Balzer B; Amin MB
Am J Surg Pathol; 2013 Dec; 37(12):1815-23. PubMed ID: 24225842
[TBL] [Abstract][Full Text] [Related]
39. Useful immunohistochemical panel for differentiating clear cell papillary renal cell carcinoma from its mimics.
Pramick M; Ziober A; Bing Z
Ann Diagn Pathol; 2013 Oct; 17(5):437-40. PubMed ID: 23791764
[TBL] [Abstract][Full Text] [Related]
40. Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer.
Luo J; Zha S; Gage WR; Dunn TA; Hicks JL; Bennett CJ; Ewing CM; Platz EA; Ferdinandusse S; Wanders RJ; Trent JM; Isaacs WB; De Marzo AM
Cancer Res; 2002 Apr; 62(8):2220-6. PubMed ID: 11956072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
